Trial Profile
Efficacy and tolerability of Fixed Dose Combination of Perindopril plus Indapamide plus Amlodipine in patients with grade II/III hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Jul 2019
Price :
$35
*
At a glance
- Drugs Amlodipine/indapamide/perindopril (Primary)
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Serdia Pharmaceuticals
- 21 Aug 2018 Status changed from recruiting to completed.
- 15 Dec 2017 Status changed from not yet recruiting to recruiting.
- 14 Dec 2017 New trial record